Skip to main content

Advertisement

Log in

Metabolic syndrome: a follow-up study of acute depressive inpatients

  • Original Paper
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

Previous studies pointed out the high prevalence of the metabolic syndrome among patients with bipolar disorder and major depression. A link between depression and a metabolic syndrome remains in dispute despite these studies. This study was conducted to evaluate the occurrence of the metabolic syndrome in depressive inpatients, to analyze the association between the severity of depression and the metabolic syndrome and to screen specific laboratory values in the course of depressive illness. 60 acute depressive patients were recruited for the study and underwent psychometric testing [21-item Hamilton Depression Rating Scale (HAMD), Beck Depression Inventory (BDI), Clinical Global Impression Scale (CGI) and Global Assessment of Functioning Scale (GAF)] and a metabolic syndrome screening using the modified criteria of the American National Cholesterol Education Program (NCEP) Treatment Panel III (ATP III). Moreover, CRP, cholesterol, HDL-cholesterol, fasting glucose, triglyceride and leptin levels were measured. 42 patients were reexamined in state of (partial) remission. Depression was reassessed using the 21-item HAMD, and laboratory values were analyzed a second time. 25% of the depressive patients fulfilled the criteria of metabolic syndrome (MS+). Only in the MS+ group, a positive correlation between triglyceride blood levels and severity of depression became evident as well in the state of acute depression as in the state of remission. In the group of patients without metabolic syndrome, laboratory values were not associated with severity of depression. An association between metabolic parameters and the course of depression could only be detected in the group of patients with metabolic syndrome. These findings suggest that, in these patients, a beneficial outcome of depressive illness may improve the metabolic situation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Al-Nozha M, Al-Khadra A, Arafah MR, Al-Maatouq MA, Khalil MZ, Khan NB, Al-Mazrou YY, Al-Marzouki K, Al-Harthi SS, Abdullah M, Al-Shahid MS, Al-Mobeireek A, Nouh MS (2005) Metabolic syndrome in Saudi Arabia. Saudi Med J 26:1918–1925

    PubMed  Google Scholar 

  2. Eich D, Neuhaus C, Gamma A, Angst J, Rössler W, Ajdacic-Gross V, Opravil M (2007) Is depression a risk factor for heart complaints? Longitudinal aspects in the Zurich study. Eur Arch Psychiatry Clin Neurosci 257:396–401

    Article  PubMed  Google Scholar 

  3. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ (2005) Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 7:424–430

    Article  PubMed  Google Scholar 

  4. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356–359

    Article  PubMed  Google Scholar 

  5. Glueck CJ, Tieger M, Kunkel R, Tracy T, Speirs J, Streicher P, Illig E (1993) Improvement in symptoms of depression and in an index of life stressors accompany treatment of severe hypertriglyceridemia. Biol Psychiatry 34:240–252

    Article  CAS  PubMed  Google Scholar 

  6. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752

    Article  PubMed  Google Scholar 

  7. Guize L, Thomas F, Pannier B, Bean K, Danchin N, Bénétos A (2006) Metabolic syndrome: prevalence, risk factors and mortality in a French population of 62,000 subjects. Bull Acad Natl Med 190:685–700

    PubMed  Google Scholar 

  8. Heiskanen TH, Niskanen LK, Hintikka JJ, Koivumaa-Honkanen HT, Honkalampi KM, Haatainen KM, Viinamäki HT (2006) Metabolic syndrome and depression: a cross-sectional analysis. J Clin Psychiatry 67:1422–1427

    Article  PubMed  Google Scholar 

  9. Herva A, Räsänen P, Miettunen J, Timonen M, Läksy K, Veijola J, Laitinen J, Ruokonen A, Joukamaa M (2006) Co-occurrence of metabolic syndrome with depression and anxiety in young adults: the Northern Finland 1966 Birth Cohort Study. Psychosom Med 68:213–216

    Article  PubMed  Google Scholar 

  10. Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP (2004) Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom Med 66:316–322

    Article  PubMed  Google Scholar 

  11. Kopf D, Deuschle M (2005) Lipid metabolism and insulin resistance in depressive patients. Psychoneuro 31:212–216

    Article  Google Scholar 

  12. Koponen H, Jokelainen J, Keinänen-Kiukaanniemi S, Kumpusalo E, Vanhala M (2008) Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study. J Clin Psychiatry 69:178–182

    Article  PubMed  Google Scholar 

  13. Moebus S, Hanisch JU, Aidelsburger P, Bramlage P, Wasem J, Jöckel KH (2007) Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol 6:22

    Article  PubMed  Google Scholar 

  14. Neuhauser H, Ellert U (2005) Prävalenz des metabolischen Syndroms in Deutschland: eine Sensitivitätsanalyse. GMS German Medical Science Doc05gmds416. http://www.egms.de/en/meetings/gmds2005/05gmds183.shtml

  15. Penttinen J (1995) Hypothesis: low serum cholesterol, suicide, and interleukin-2. Am J Epidemiol 141:716–718

    CAS  PubMed  Google Scholar 

  16. Pjerk E, Winkler D, Abramson DW, Konstantinidis A, Stastny J, Willeit M, Praschk-Rieder N, Kasper S (2007) Serum lipid levels in seasonal affective disorder. Eur Arch Psychiatry Clin Neurosci 257:197–202

    Article  Google Scholar 

  17. Sheikh N, Farhadi Nasab A, Araghchian M, Mani Kashani Kh (2004) The relationship of cholesterol and triglyceride with depression. Acta Med Iran 42:185–187

    Google Scholar 

  18. Teixeira PJ, Rocha FL (2007) The prevalence of metabolic syndrome among psychiatric inpatients in Brazil. Rev Bras Psiquiatr 29:330–336

    Article  PubMed  Google Scholar 

  19. Tuomilehto J (2005) Cardiovascular risk: prevention and treatment of the metabolic syndrome. Diabetes Res Clin Pract 68(Suppl 2):28–35

    Article  Google Scholar 

  20. Vaccarino V, McClure C, Johnson BD, Sheps DS, Bittner V, Rutledge T, Shaw LJ, Sopko G, Olson MB, Krantz DS, Parashar S, Marroquin OC, Merz CN (2008) Depression, the metabolic syndrome and cardiovascular risk. Psychosom Med 70:40–48

    Article  PubMed  Google Scholar 

  21. Vogelzangs N, Suthers K, Ferrucci L, Simonsick EM, Ble A, Schrager M, Bandinelli S, Lauretani F, Giannelli SV, Penninx BW (2007) Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology 32:151–159

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H.-J. Assion.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Richter, N., Juckel, G. & Assion, HJ. Metabolic syndrome: a follow-up study of acute depressive inpatients. Eur Arch Psychiatry Clin Neurosci 260, 41–49 (2010). https://doi.org/10.1007/s00406-009-0013-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-009-0013-5

Keywords

Navigation